NO863671D0 - Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.Info
- Publication number
- NO863671D0 NO863671D0 NO863671A NO863671A NO863671D0 NO 863671 D0 NO863671 D0 NO 863671D0 NO 863671 A NO863671 A NO 863671A NO 863671 A NO863671 A NO 863671A NO 863671 D0 NO863671 D0 NO 863671D0
- Authority
- NO
- Norway
- Prior art keywords
- heterocycloylkylpyrido
- indoles
- procedure
- preparation
- therapeutic active
- Prior art date
Links
- 150000002475 indoles Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/776,180 US4636563A (en) | 1985-09-16 | 1985-09-16 | Antipsychotic γ-carbolines |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO863671D0 true NO863671D0 (no) | 1986-09-15 |
| NO863671L NO863671L (no) | 1987-03-17 |
| NO163619B NO163619B (no) | 1990-03-19 |
| NO163619C NO163619C (no) | 1990-06-27 |
Family
ID=25106686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO863671A NO163619C (no) | 1985-09-16 | 1986-09-15 | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro- 2-heterocykloalkylpyrido(4,3)indoler. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US4636563A (no) |
| EP (1) | EP0223344B1 (no) |
| JP (1) | JPS6267083A (no) |
| KR (1) | KR900002245B1 (no) |
| CN (1) | CN1013864B (no) |
| AR (1) | AR242208A1 (no) |
| AT (1) | ATE55770T1 (no) |
| AU (1) | AU590605B2 (no) |
| CA (1) | CA1275099A (no) |
| CY (1) | CY1595A (no) |
| DE (1) | DE3673607D1 (no) |
| DK (1) | DK440686A (no) |
| EG (1) | EG18015A (no) |
| ES (1) | ES2002656A6 (no) |
| FI (1) | FI83318C (no) |
| GB (1) | GB2180536B (no) |
| GR (1) | GR862343B (no) |
| HK (1) | HK53491A (no) |
| HU (1) | HU195217B (no) |
| IL (1) | IL79956A0 (no) |
| MX (1) | MX3681A (no) |
| NO (1) | NO163619C (no) |
| NZ (1) | NZ217580A (no) |
| PH (1) | PH22515A (no) |
| PT (1) | PT83344B (no) |
| SU (1) | SU1442074A3 (no) |
| YU (1) | YU45023B (no) |
| ZA (1) | ZA866258B (no) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5328905A (en) * | 1987-07-20 | 1994-07-12 | Duphar International Research B.V. | 8,9-anellated-1,2,3,4-tetrahydro-β-carboline derivatives |
| US5360800A (en) * | 1987-09-03 | 1994-11-01 | Glaxo Group Limited | Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives |
| US4798896A (en) * | 1988-01-19 | 1989-01-17 | American Home Products Corporation | Antipsychotic gamma-carboline N-oxides |
| HU207078B (en) * | 1988-08-02 | 1993-03-01 | Glaxo Group Ltd | Process for producing lactam derivatives and pharmaceutical compositions comprising such compounds |
| JPH02167280A (ja) * | 1988-08-15 | 1990-06-27 | Glaxo Group Ltd | ラクタム誘導体 |
| US5021569A (en) * | 1990-06-12 | 1991-06-04 | American Home Products Corporation | 4-azatricyclo[4.3.1.1(3,8)]undecylarylpiperazines with anxiolytic activity |
| US5631017A (en) * | 1993-03-26 | 1997-05-20 | Beth Israel Deaconess Medical Center, Inc. | Topical application of buspirone for treatment of pathological conditions associated with immune responses |
| US5484788A (en) * | 1993-03-26 | 1996-01-16 | Beth Israel Hospital Association | Buspirone as a systemic immunosuppressant |
| FR2715659B1 (fr) * | 1994-02-03 | 1996-03-22 | Synthelabo | Dérivés de 3-(2-aminoéthyl)-4-[3-(trifluorométhyl)benzoyl]-3,4-dihydro-2H-1,4-benzoxazine, leur préparation et leur application en thérapeutique. |
| CN1109880A (zh) * | 1994-02-03 | 1995-10-11 | 合成实验室公司 | 3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3,4-二氢-2h-1,4-苯并噁嗪衍生物、制备及其应用 |
| ATE247114T1 (de) * | 1994-09-12 | 2003-08-15 | Lilly Co Eli | Serotonergische modulatoren |
| JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
| US5637314A (en) * | 1995-06-07 | 1997-06-10 | Beth Israel Deaconess Medical Center, Inc. | Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis |
| RU2106864C1 (ru) * | 1995-10-23 | 1998-03-20 | Николай Серафимович Зефиров | Средство для лечения болезни альцгеймера |
| EP0905136A1 (en) * | 1997-09-08 | 1999-03-31 | Janssen Pharmaceutica N.V. | Tetrahydro gamma-carbolines |
| RU2283108C2 (ru) * | 2003-12-08 | 2006-09-10 | Сергей Олегович Бачурин | ГЕРОПРОТЕКТОР НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
| US20070179174A1 (en) * | 2003-12-08 | 2007-08-02 | Bachurin Sergei O | Methods and compositions for slowing aging |
| AU2006275694A1 (en) * | 2005-07-28 | 2007-02-08 | Bristol-Myers Squibb Company | Substituted tetrahydro-1H-pyrido(4,3,b)indoles as serotonin receptor agonists and antagonists |
| CA2624731A1 (en) * | 2005-10-04 | 2007-04-12 | Medivation, Inc. | Hydrogenated pyrido-indole compounds for the treatment of huntington's disease |
| RU2338537C2 (ru) * | 2006-01-25 | 2008-11-20 | Сергей Олегович Бачурин | СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ШИЗОФРЕНИИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670010A1 (de) * | 1966-12-07 | 1970-07-30 | Abbott Lab | Aroylalkylderivate von 1,2,3,4-Tetrahydro-5H-pyride-[4,3b]-indolen und Verfahren zur Herstellung derselben |
| US3502688A (en) * | 1968-09-10 | 1970-03-24 | Hoffmann La Roche | 5-(4-pyridylethyl)-pyridoindole derivatives |
| US3522262A (en) * | 1968-09-10 | 1970-07-28 | Hoffmann La Roche | 5-(pyridylalkyl)-pyridoindole derivatives |
| DE1952800C3 (de) * | 1969-10-20 | 1974-04-18 | Nautschno-Issledowatelskij Institut Farmakologii I Chimioterapii, Moskau | 3,6-Dimethyl-l,2,3,4,4a,9a-hexahydro-gamma-carbolin-dihydrochlorid |
| US4001263A (en) * | 1974-04-01 | 1977-01-04 | Pfizer Inc. | 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines |
| DE2621729A1 (de) * | 1976-05-15 | 1977-12-08 | Boehringer Sohn Ingelheim | Neue 2-(4-phenyl-4-cyanobutyl)-1,2, 3,4-tetrahydro-5(h)-pyrido- eckige klammer auf 4,3-b eckige klammer zu -indole und verfahren zu ihrer herstellung |
| US4224329A (en) * | 1979-01-23 | 1980-09-23 | Pfizer Inc. | 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles |
| US4337250A (en) * | 1979-07-30 | 1982-06-29 | Pfizer Inc. | Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents |
| US4672117A (en) * | 1985-09-16 | 1987-06-09 | American Home Products Corporation | Antipsychotic gamma-carbolines |
| NZ226032A (en) * | 1987-09-03 | 1991-12-23 | Glaxo Group Ltd | 2-(imidazolylmethyl)-pyrido or-azepino(4,3-b)indole-1(2h)-one derivatives; preparatory processes and pharmaceutical compositions |
-
1985
- 1985-09-16 US US06/776,180 patent/US4636563A/en not_active Expired - Fee Related
-
1986
- 1986-08-19 ZA ZA866258A patent/ZA866258B/xx unknown
- 1986-08-25 AU AU61813/86A patent/AU590605B2/en not_active Ceased
- 1986-09-02 AT AT86306745T patent/ATE55770T1/de not_active IP Right Cessation
- 1986-09-02 EP EP86306745A patent/EP0223344B1/en not_active Expired - Lifetime
- 1986-09-02 DE DE8686306745T patent/DE3673607D1/de not_active Expired - Fee Related
- 1986-09-03 GB GB8621226A patent/GB2180536B/en not_active Expired
- 1986-09-05 IL IL79956A patent/IL79956A0/xx not_active IP Right Cessation
- 1986-09-05 AR AR86305167A patent/AR242208A1/es active
- 1986-09-08 MX MX368186A patent/MX3681A/es unknown
- 1986-09-08 PH PH34230A patent/PH22515A/en unknown
- 1986-09-10 PT PT83344A patent/PT83344B/pt not_active IP Right Cessation
- 1986-09-10 YU YU1576/86A patent/YU45023B/xx unknown
- 1986-09-11 CA CA000517999A patent/CA1275099A/en not_active Expired - Fee Related
- 1986-09-12 GR GR862343A patent/GR862343B/el unknown
- 1986-09-12 JP JP61216964A patent/JPS6267083A/ja active Pending
- 1986-09-12 FI FI863692A patent/FI83318C/fi not_active IP Right Cessation
- 1986-09-12 SU SU864028180A patent/SU1442074A3/ru active
- 1986-09-12 ES ES8601849A patent/ES2002656A6/es not_active Expired
- 1986-09-13 CN CN86106194A patent/CN1013864B/zh not_active Expired
- 1986-09-15 HU HU863942A patent/HU195217B/hu not_active IP Right Cessation
- 1986-09-15 KR KR1019860007738A patent/KR900002245B1/ko not_active Expired
- 1986-09-15 NZ NZ217580A patent/NZ217580A/xx unknown
- 1986-09-15 EG EG581/86A patent/EG18015A/xx active
- 1986-09-15 NO NO863671A patent/NO163619C/no unknown
- 1986-09-15 DK DK440686A patent/DK440686A/da not_active Application Discontinuation
-
1991
- 1991-07-11 HK HK534/91A patent/HK53491A/xx unknown
-
1992
- 1992-04-03 CY CY1595A patent/CY1595A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO853046L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
| NO870075D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO166639C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner. | |
| NO871267D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
| NO870526D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
| NO874869L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
| NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO863671L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler. | |
| NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
| NO166080C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner. | |
| NO864674D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser. | |
| NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
| NO864131D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater. | |
| NO166326C (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater. | |
| NO875488D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO873108D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner. | |
| NO861584L (no) | Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere. | |
| NO864101D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
| NO860091L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater. |